InsidersTradesSigma
Follow the Instil Bio, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Instil Bio, Inc. has published 2 public disclosures. Market capitalisation: €50.3m. The latest transaction was reported on 12 September 2025 (Levée d'options). Among the most active insiders: Laumas Sandeep. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Instil Bio, Inc. Hold (neutral), based on 1 analysts. Average price target: US$7.00.
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 September 2025
Declarations2 total
17,000 shares@ US$11.60100.0% of flowCommon StockSEC:0001789769-25-000087:0
260,323 shares0Common StockSEC:0001567619-22-007150:0
2 of 2 declarations
Acerca de Instil Bio, Inc.
Instil Bio, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias celulares para el tratamiento del cáncer. Utiliza tecnologías avanzadas para crear terapias innovadoras y personalizadas.